MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Firdapse$358,380K Agamree$117,086K Fycompa$113,341K Product Revenue Net$588,807K License And OtherRevenue$182K Total revenues$588,989K Operating income$257,778K Other income, net$25,737K Total operating costsand expenses$331,211K Net income beforeincome taxes$283,515K Selling, general andadministrative$193,751K Cost of sales$87,253K Amortization of intangibleassets$37,498K Research and development$12,709K Net income$214,326K Income tax provision$69,189K Comprehensive income$214,262K Unrealized gain (loss) onavailable-for-sale securities, net...-$64K
Income Statement
source: myfinsight.com

CATALYST PHARMACEUTICALS, INC. (CPRX)

CATALYST PHARMACEUTICALS, INC. (CPRX)